MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Investigating the clinical predictors of depression in Huntington’s disease: An Enroll-HD Database Study

E. Furr Stimming, G. Colpo, N. Rocha, A. Teixeira (Houston, TX, USA)

Meeting: 2018 International Congress

Abstract Number: 822

Keywords: Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features

Session Information

Date: Sunday, October 7, 2018

Session Title: Huntington's Disease

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: This study was designed to investigate clinical predictors of depression in subjects with HD.

Background: Huntington’s disease (HD) is characterized by motor, cognitive and behavioral changes. Among several psychiatric symptoms, depression is of great relevance as it is considered a significant burden for both individuals with HD and their caregivers. In addition, the presence of depression is a predictor of suicidal ideation, attempts and completion. Despite the high frequency and significance of depressive symptoms in HD, there is a lack of predictive and prognostic data to guide clinicians in its management.

Methods: This study included 2,303 subjects with manifest HD from the Enroll-HD Database (December, 2015). A binary logistic regression (backward stepwise approach) was performed to ascertain the effects of general clinical characteristics, medical history of substance use and psychiatric/behavioral problems, motor and functional capacity and cognitive performance on the likelihood that subjects with HD present depression or suicidal ideation.

Results: In the final model (χ2 = 270.648, p < 0.0001), younger age at HD clinical diagnosis (OR=0.969, p=0.001), lower number of CAG repeats (OR=0.904, p=0.002), clinical history of irritability (OR=2.119, p<0.0001), violent/aggressive behavior (OR=1.492, p=0.040), apathy (OR=3.631, p<0.0001), psychosis (OR=3.658, p=0.001) and cognitive impairment (OR=1.409, p=0.024)], and female sex (OR=2.124, p<0.0001) remained as predictors on the likelihood of depression. Additional analyses revealed that depression was significantly associated with suicidal ideation (52.2% of subjects HD presenting history of depression had suicidal ideation, while only 7.5% of patients without history of depression had suicidal ideation, p<0.0001).

Conclusions: Depression is associated with a younger age at motor manifestations and a lower number of CAG repeats. Female sex, behavioral problems (noteworthy apathy and psychosis) and poorer cognitive performance were also predictors for depression in HD. This information can be used to guide clinicians when evaluating and treating depression in individuals with HD and more importantly, prompt clinicians to routinely screen patients for suicidal ideations in hopes of decreasing the frequency of suicidal attempts and completion in HD.

To cite this abstract in AMA style:

E. Furr Stimming, G. Colpo, N. Rocha, A. Teixeira. Investigating the clinical predictors of depression in Huntington’s disease: An Enroll-HD Database Study [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/investigating-the-clinical-predictors-of-depression-in-huntingtons-disease-an-enroll-hd-database-study/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/investigating-the-clinical-predictors-of-depression-in-huntingtons-disease-an-enroll-hd-database-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley